Anti-CEA CAR-T cell therapy in CRC patients, although mediating regression of metastatic colorectal cancer, induced severe transient inflammatory colitis due to CEA expression in healthy intestinal epithelium [132]. Here, CEACAM5 is linked to colorectal carcinoma.